CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RPRX — Royalty Pharma plc
CIK 884546
SAN FRANCISCO, CA
Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$172,893,414
+$27,645,099 QoQ
Shares Held
3,083,528
+1.8% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#24
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RPRX ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,893,414 | 3,083,528 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $145,248,315 | 3,027,899 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $112,573,698 | 2,913,398 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $106,747,119 | 3,025,712 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $108,408,397 | 3,008,837 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $97,204,390 | 3,122,531 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $79,887,830 | 3,131,628 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $84,915,348 | 3,001,603 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $50,057,168 | 1,898,262 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $55,668,361 | 1,833,005 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $49,747,052 | 1,770,988 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $44,751,254 | 1,648,904 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $45,359,605 | 1,475,589 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $50,713,558 | 1,407,537 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $53,793,794 | 1,361,179 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $51,321,230 | 1,277,283 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,072,661 | 1,167,285 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $41,859,442 | 1,074,421 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $39,375,227 | 988,086 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $34,192,017 | 946,099 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $10,896,166 | 265,825 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,692,875 | 245,137 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,034,075 | 180,501 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,038,949 | 214,855 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,848,932 | 161,667 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||